CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes Association of Left Ventricular Systolic Function With Incident Heart Failure in Late Life The multiple causes and treatments of heart failure: focus on genetic and molecular mechanisms and non-pharmacological interventions Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial Sodium-Glucose Co-Transporter 2 Inhibitors and Insights from Biomarker Measurement in Heart Failure Patients Modifiable lifestyle factors and heart failure: A Mendelian randomization study Empagliflozin, Health Status, and Quality of Life in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure

Original Research2018 May 15;137(20):2101-2103.

JOURNAL:Circulation. Article Link

Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study

Januzzi JL Jr, Richards AM. Keywords: biomarkers; evidence-based medicine; guideline adherence; heart failure; natriuretic peptides

LINK


Please click on the "Article Link" to access the article.